The Starting Treatment for Ethanol in Primary care Trials (STEP Trials): Protocol for Three Parallel Multi-Site Stepped Care Effectiveness Studies for Unhealthy Alcohol Use in HIV-Positive Patients.

[1]  Richard D Moore,et al.  Heavy Alcohol Use Is Associated With Worse Retention in HIV Care , 2016, Journal of acquired immune deficiency syndromes.

[2]  Brandon D. L. Marshall,et al.  Risk of mortality and physiologic injury evident with lower alcohol exposure among HIV infected compared with uninfected men. , 2016, Drug and alcohol dependence.

[3]  K. Kraemer,et al.  Number of Drinks to “Feel a Buzz” by HIV Status and Viral Load in Men , 2016, AIDS and Behavior.

[4]  L. Fiellin,et al.  Implementation of integrated stepped care for unhealthy alcohol use in HIV clinics , 2016, Addiction Science & Clinical Practice.

[5]  A. Raj,et al.  Engagement and Substance Dependence in a Primary Care-Based Addiction Treatment Program for People Infected with HIV and People at High-Risk for HIV Infection. , 2015, Journal of substance abuse treatment.

[6]  F. Wurst,et al.  Ethanol metabolites: their role in the assessment of alcohol intake. , 2015, Alcoholism, clinical and experimental research.

[7]  J. Franck,et al.  Phosphatidylethanol is superior to carbohydrate-deficient transferrin and γ-glutamyltransferase as an alcohol marker and is a reliable estimate of alcohol consumption level. , 2015, Alcoholism, clinical and experimental research.

[8]  D. Patrick,et al.  Patient and provider priorities for self-reported domains of HIV clinical care , 2015, AIDS care.

[9]  Alex H. S. Harris,et al.  Examining the Specification Validity of the HEDIS Quality Measures for Substance Use Disorders. , 2015, Journal of substance abuse treatment.

[10]  Samantha D. Outcalt,et al.  Evaluation of Stepped Care for Chronic Pain (ESCAPE) in Veterans of the Iraq and Afghanistan Conflicts: A Randomized Clinical Trial. , 2015, JAMA internal medicine.

[11]  C. Kahler,et al.  Attitudes and Training Needs of New England HIV Care and Addiction Treatment Providers: Opportunities for Better Integration of HIV and Alcohol Treatment Services , 2015, Addictive disorders & their treatment.

[12]  A. O'Leary,et al.  Perceived medical risks of drinking, alcohol consumption, and hepatitis C status among heavily drinking HIV primary care patients. , 2014, Alcoholism, clinical and experimental research.

[13]  E. Williams,et al.  An early evaluation of implementation of brief intervention for unhealthy alcohol use in the US Veterans Health Administration. , 2014, Addiction.

[14]  A. Justice,et al.  Relationship between alcohol use categories and noninvasive markers of advanced hepatic fibrosis in HIV-infected, chronic hepatitis C virus-infected, and uninfected patients. , 2014, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

[15]  P. Cuijpers,et al.  Stepped care treatment delivery for depression: a systematic review and meta-analysis , 2014, Psychological Medicine.

[16]  Jackson T. Wright,et al.  2014 evidence-based guideline for the management of high blood pressure in adults: report from the panel members appointed to the Eighth Joint National Committee (JNC 8). , 2014, JAMA.

[17]  R. Rosenheck,et al.  Long-acting injectable depot naltrexone use in the Veterans' Health Administration: a national study. , 2014, Addictive behaviors.

[18]  B. Agan,et al.  The VACS Index Predicts Mortality in a Young, Healthy HIV Population Starting Highly Active Antiretroviral Therapy , 2014, Journal of acquired immune deficiency syndromes.

[19]  E. Kaner,et al.  The Impact of Brief Alcohol Interventions in Primary Healthcare: A Systematic Review of Reviews , 2013, Alcohol and alcoholism.

[20]  R. Rosenheck,et al.  Use of naltrexone for alcohol use disorders in the Veterans' Health Administration: a national study. , 2013, Drug and alcohol dependence.

[21]  E. Walker,et al.  Diagnostic and Statistical Manual of Mental Disorders , 2013 .

[22]  K. Kraemer,et al.  HIV infection and the risk of acute myocardial infarction. , 2013, JAMA internal medicine.

[23]  Timothy R Sterling,et al.  An internationally generalizable risk index for mortality after one year of antiretroviral therapy , 2013, AIDS.

[24]  Richard D Moore,et al.  Predictive Accuracy of the Veterans Aging Cohort Study Index for Mortality With HIV Infection: A North American Cross Cohort Analysis , 2013, Journal of acquired immune deficiency syndromes.

[25]  Alex H. S. Harris,et al.  Pharmacotherapy for alcohol dependence: perceived treatment barriers and action strategies among Veterans Health Administration service providers. , 2013, Psychological services.

[26]  Guido Viel,et al.  Phosphatidylethanol in Blood as a Marker of Chronic Alcohol Use: A Systematic Review and Meta-Analysis , 2012, International journal of molecular sciences.

[27]  B. Turner,et al.  Systematic review: effect of alcohol intake on adherence to outpatient medication regimens for chronic diseases. , 2012, Journal of studies on alcohol and drugs.

[28]  K. Kraemer,et al.  Unhealthy Alcohol and Illicit Drug Use Are Associated With Decreased Quality of HIV Care , 2012, Journal of acquired immune deficiency syndromes.

[29]  G. D’Onofrio,et al.  A brief intervention reduces hazardous and harmful drinking in emergency department patients. , 2012, Annals of emergency medicine.

[30]  V. Gruber,et al.  Untreated HIV Infection Is Associated With Higher Blood Alcohol Levels , 2012, Journal of acquired immune deficiency syndromes.

[31]  L. Kuller,et al.  Does an index composed of clinical data reflect effects of inflammation, coagulation, and monocyte activation on mortality among those aging with HIV? , 2012, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

[32]  C. Torti,et al.  Evaluation of liver fibrosis: concordance analysis between noninvasive scores (APRI and FIB-4) evolution and predictors in a cohort of HIV-infected patients without hepatitis C and B infection. , 2011, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

[33]  B. Gazzard,et al.  Increasing burden of liver disease in patients with HIV infection , 2011, The Lancet.

[34]  Harold Alan Pincus,et al.  Can Psychiatry Cross the Quality Chasm? Improving the Quality of Health Care For Mental and Substance Use Conditions , 2011 .

[35]  F. Altice,et al.  Integration of Buprenorphine/Naloxone Treatment into HIV Clinical Care: Lessons From the BHIVES Collaborative , 2011, Journal of acquired immune deficiency syndromes.

[36]  F. Altice,et al.  Drug Treatment Outcomes Among HIV-Infected Opioid-Dependent Patients Receiving Buprenorphine/Naloxone , 2011, Journal of acquired immune deficiency syndromes.

[37]  Lei Liu,et al.  Percentage of subjects with no heavy drinking days: evaluation as an efficacy endpoint for alcohol clinical trials. , 2010, Alcoholism, clinical and experimental research.

[38]  J. Hahn,et al.  Alcohol and HIV Disease Progression: Weighing the Evidence , 2010, Current HIV/AIDS reports.

[39]  N. Petry,et al.  Multisite effectiveness trials of treatments for substance abuse and co-occurring problems: have we chosen the best designs? , 2010, Journal of Substance Abuse Treatment.

[40]  K. Covinsky,et al.  Towards a combined prognostic index for survival in HIV infection: the role of ‘non‐HIV’ biomarkers , 2010, HIV medicine.

[41]  M. Webb Brief Intervention for Hazardous and Harmful Drinkers in the Emergency Department , 2009 .

[42]  R. Norman,et al.  HIV care providers' implementation of routine alcohol reduction support for their patients. , 2009, AIDS patient care and STDs.

[43]  L. Metsch,et al.  HIV-positive patients' discussion of alcohol use with their HIV primary care providers. , 2008, Drug and alcohol dependence.

[44]  Declan T. Barry,et al.  Long-term treatment with buprenorphine/naloxone in primary care: results at 2-5 years. , 2008, The American journal on addictions.

[45]  A. Raj,et al.  Associations Between Alcohol, Heroin, and Cocaine Use and High Risk Sexual Behaviors Among Detoxification Patients , 2007, The American journal of drug and alcohol abuse.

[46]  D. Kivlahan,et al.  Implementation of evidence-based alcohol screening in the Veterans Health Administration. , 2006, The American journal of managed care.

[47]  K. Kraemer,et al.  Intoxication Before Intercourse and Risky Sexual Behavior in Male Veterans With and Without Human Immunodeficiency Virus Infection , 2006, Medical care.

[48]  A. Justice,et al.  Role of alcohol in determining human immunodeficiency virus (HIV)-relevant outcomes: A conceptual model to guide the implementation of evidence-based interventions into practice. , 2006, Medical care.

[49]  D. Kanouse,et al.  Correlates of sex without serostatus disclosure among a national probability sample of HIV patients , 2006, AIDS and Behavior.

[50]  J. Montaner,et al.  Development of a simple noninvasive index to predict significant fibrosis in patients with HIV/HCV coinfection , 2006, Hepatology.

[51]  David Couper,et al.  Combined pharmacotherapies and behavioral interventions for alcohol dependence: the COMBINE study: a randomized controlled trial. , 2006, JAMA.

[52]  Alan Y. Chiang,et al.  Data Analysis of Asymmetric Structures: Advanced Approaches in Computational Statistics , 2006, Technometrics.

[53]  Neil Skolnik,et al.  Helping Patients Who Drink Too Much , 2005 .

[54]  Joseph Conigliaro,et al.  A temporal and dose-response association between alcohol consumption and medication adherence among veterans in care. , 2005, Alcoholism, clinical and experimental research.

[55]  L. Degutis,et al.  Development and implementation of an emergency practitioner-performed brief intervention for hazardous and harmful drinkers in the emergency department. , 2005, Academic emergency medicine : official journal of the Society for Academic Emergency Medicine.

[56]  R. Saitz Clinical practice. Unhealthy alcohol use. , 2005, The New England journal of medicine.

[57]  Peter W. Dillingham,et al.  Pharmacy-based assessment of adherence to HAART predicts virologic and immunologic treatment response and clinical progression to AIDS and death , 2004, International journal of STD & AIDS.

[58]  Geert Molenberghs,et al.  Analyzing incomplete longitudinal clinical trial data. , 2004, Biostatistics.

[59]  Julio S. G. Montaner,et al.  Effect of Medication Adherence on Survival of HIV-Infected Adults Who Start Highly Active Antiretroviral Therapy When the CD4+ Cell Count Is 0.200 to 0.350 109 cells/L , 2003, Annals of Internal Medicine.

[60]  D. Kanouse,et al.  Sex without disclosure of positive HIV serostatus in a US probability sample of persons receiving medical care for HIV infection. , 2003, American journal of public health.

[61]  B. Yip,et al.  Intermittent use of triple-combination therapy is predictive of mortality at baseline and after 1 year of follow-up , 2002, AIDS.

[62]  K. Fletcher,et al.  Handbook of Psychiatric Measures , 2002 .

[63]  K. Kraemer,et al.  Effects of two types of brief intervention and readiness to change on alcohol use in hazardous drinkers. , 2001, Journal of studies on alcohol.

[64]  L. Sobell,et al.  Stepped care as a heuristic approach to the treatment of alcohol problems. , 2000, Journal of consulting and clinical psychology.

[65]  Michael B. First,et al.  Handbook of Psychiatric Measures , 2000 .

[66]  P. O'Connor,et al.  Screening for alcohol problems in primary care: a systematic review. , 2000, Archives of internal medicine.

[67]  D. Kivlahan,et al.  The AUDIT Alcohol consumption questions (AUDIT-C) : An effective brief screening test for problem drinking , 1998 .

[68]  K. Barry,et al.  Brief physician advice for problem alcohol drinkers. A randomized controlled trial in community-based primary care practices. , 1997, JAMA.

[69]  D. Metzger,et al.  The Fifth Edition of the Addiction Severity Index. , 1992, Journal of substance abuse treatment.

[70]  A. Alterman,et al.  A New Measure of Substance Abuse Treatment Initial Studies of the Treatment Services Review , 1992, The Journal of nervous and mental disease.

[71]  L. Kozlowski,et al.  The Fagerström Test for Nicotine Dependence: a revision of the Fagerström Tolerance Questionnaire. , 1991, British journal of addiction.

[72]  T D Koepsell,et al.  A General Method of Compliance Assessment Using Centralized Pharmacy Records: Description and Validation , 1988, Medical care.

[73]  A. Justice,et al.  Using the VACS index to track health outcomes associated with abstinence among HIV-infected patients receiving opioid agonist treatment , 2015 .

[74]  J. Crippa,et al.  Psychometric properties of the Fagerström Test for Nicotine Dependence. , 2009, Jornal brasileiro de pneumologia : publicacao oficial da Sociedade Brasileira de Pneumologia e Tisilogia.

[75]  R. Norman,et al.  HIV Care Providers' Role Legitimacy as Supporters of Their Patients' Alcohol Reduction. , 2009, The open infectious diseases journal.

[76]  F. Fantozzi,et al.  Helping patients who drinks too much. A Clinician’s Guide , 2006 .

[77]  R. Spitzer,et al.  The PHQ-9: validity of a brief depression severity measure. , 2001, Journal of general internal medicine.

[78]  D. Kivlahan,et al.  The AUDIT alcohol consumption questions (AUDIT-C): an effective brief screening test for problem drinking. Ambulatory Care Quality Improvement Project (ACQUIP). Alcohol Use Disorders Identification Test. , 1998, Archives of internal medicine.

[79]  C. Brandt,et al.  Application of Technology: Managing Attribute-Value Clinical Trials Data Using the ACT/DB Client-Server Database System , 1998, J. Am. Medical Informatics Assoc..

[80]  Matching Alcoholism Treatments to Client Heterogeneity: Project MATCH posttreatment drinking outcomes. , 1997, Journal of studies on alcohol.